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Deadly Dust: A mysterious fungus has been sickening residents of California's Central 
Valley for hundreds of years. No one has seemed to care until now. 
 
 
Last fall, Kirt Emery was riding on his motorcycle, cruising up the 99 freeway over the 
mountains from Santa Barbara to Bakersfield, when he saw the dust storm materializing 
in front of him. Visibility was low, but he wanted to get through it as quickly as he could, 
so he held his breath and hammered his bike up to 100 miles an hour.  
 
As the head of epidemiology for the Bakersfield Public Health Services Department, 
Emery, whose tanned face and faint white moustache suggests frequent rides on his bike, 
has spent the past two decades studying dust like this – and avoiding it at all costs. He 
knows all too well what could happen to him if he got sick: the expensive medications 
with their nasty side affects, the uncertainty of whether he could be ill for the rest of his 
life.   
 
It’s been more than twenty years since he moved to Bakersfield, and so far, he’s 
remained unharmed. That makes him one of the lucky ones. For many people living in 
places like Bakersfield, and throughout much of California’s Central Valley, dust can be 
deadly.  
 
Coccidioidomycosis, also known as cocci, or valley fever, is a fungal disease endemic to 
the soils of the Southwest in places like Arizona, Nevada, New Mexico, Texas and Utah. 
In California, it’s rampant across the Central Valley, an area just slightly smaller than 
West Virginia that grows most of the country’s produce. About 30 percent of all valley 
fever cases nationwide occur in the Central Valley each year.  
 
Cocci is a puzzling and intimidating pathogen, one that has perplexed doctors and 
patients alike for more than a century. Symptoms of valley fever range from mild fatigue 
to incapacitating, flesh-eating infections, and despite decades of research, little is known 
as to how the microbe operates, making advances in treatment and the push to develop a 
vaccine painfully slow. There’s virtually no way to guard against inhaling the spores that 
cause valley fever, as masks can’t filter out the microscopic dust particles that carry the 
spores into the air and into our lungs. Being infected with valley fever can be as simple as 
driving through a place like Bakersfield with the windows down – or in Emery’s case, on 
a motorcycle.  
 
For reasons still unclear, rates of valley fever are rising nationwide. Between 1998 and 
2011, documented cases across the country have increased steadily by about 15 percent 
each year, from just 2,000 infections in 1998 to more than 22,000 in 2011. In areas where 
the fungus is widespread, like Kern County, it’s statistically more probable to develop 
valley fever than hepatitis or chickenpox.   
  
Bakersfield, the largest city in Kern County, more closely resembles a sleepy town in 
America’s heartland than a city of population 358,000 just four hours south of Silicon 
Valley. It’s a town perhaps best known for the Bakersfield Sound – a genre of country 
music inspired by Dust Bowl migrants into the Central Valley, made popular by 
musicians like Merle Haggard in the 1950s – and for its incredibly profitable agriculture 
industry. Kern County, the world’s number one supplier of carrots, also grows more 
almonds and pistachios than any other area in California. Though appropriately 
nicknamed the Golden Empire for its oil derricks, multiple military bases and fertile soil, 
it also happens to be one of the poorest areas in the state. More than 22 percent of Kern’s 
population lives below the poverty line, and Bakersfield is the nation’s third most 
impoverished suburban city.  
 
It’s also one of the most polluted. Apart from the smog, which often blankets much of 
Bakersfield in a grubby haze, the city is also covered in dust, fine brown grime kicked up 
from neighboring farmlands. The dust streaks windshields and gathers on dashboards. It 
collects in piles on sidewalks, engulfs cars in sooty plumes, and crisscrosses roads, 
leaving grids of brown tire tracks. The dust is everywhere, and if you live in Bakersfield, 
you can’t escape it.  
 
Kern County’s soils have some of the highest levels of cocci fungus in the entire state. 
Between 2009 and 2011, rates of valley fever have tripled there. Researchers blame a 
population boom, increased construction – which kicks up infected soils into the 
atmosphere – and unusual weather patterns. As rainy and drought seasons become more 
erratic, rates of valley fever could continue to rise. Unusually wet years lead to massive 
cocci blooms in the soil, while subsequent dry spells kick up the spores and render them 
airborne – in dust.  
 
As valley fever escalates in Kern County, the job of getting the rest of the state to notice, 
and act, falls heavily on Emery’s shoulders.  
 
“When you look at how we report cases of cocci here in Kern County and if you ask me 
what’s being done about it, well, there’s my secretary out there and there’s me. That’s it,” 
he says. “The joke for the last month when my secretary retired was that 50 percent of the 
cocci program went away. Does Kern County invest in cocci? No, they don’t.” 
 
*** 
 
As far as disease names go, “valley fever” sounds relatively benign considering the 
variety of symptoms it can inflict on the body, ranging from outwardly nonexistent in 
some infected people, to fatal in others. Unpredictably, valley fever can spread to the 
bones, lung or brain, or it can cause nothing more than a highly phlegmy cough. It can 
also lead to blistering boils on the face, neck, chest and extremities; lesions in membranes 
of the heart and gut; it can paralyze the nerves in the face. Save for the gastrointestinal 
tract, cocci has been found in nearly every organ of the body.  
 
Most people never even know they’ve been exposed to cocci. Although once introduced 
cocci never truly leaves the body, about 60 percent of infections present no symptoms. 
Even then, however, there’s no guarantee of immunity. An infected patient will test 
positive for it for the rest of their lives, even if they never get sick. Severe stresses on the 
immune system, though, like treatment for cancer or organ transplants, can cause 
symptoms to flare up decades after exposure – another contributing factor to rising rates. 
“People with cancer are living longer, so there’s more of them available to be infected 
than there were before,” says David Stevens, chief of infectious disease at Santa Clara 
Valley Medical Center. “The evidence for that is in people who used to live in endemic 
areas like Arizona, they migrate to New England or Canada or some place that doesn’t 
have valley fever, and they haven’t been exposed to the fungus in 30 years. That proves 
that the organism is still in their body, living.”  
 
The remaining 40 percent of infections resemble the flu, or result in painful boils that 
typically clear up following a few months of treatment. But for reasons still mysterious to 
doctors, a very small percentage of valley fever infections become brutal lifelong 
illnesses. There’s scant understanding why cocci targets some people more virulently 
than others, but the amount of spores inhaled, in addition to the strength of the patient’s 
immune system and genetic predisposition, all play a role.  
 
Emery has made a career working with infectious diseases – mostly AIDS and the gamut 
of STDs. He knew valley fever would become his life’s work on November 1, 1994: his 
first day on the job in Kern County. Valley fever was one of the most peculiar public 
health issues he had ever encountered, he says, in part because the disease is highly lethal 
in certain populations like blacks and Filipinos, but has also been almost completely 
overlooked by the national spotlight. He’s since devoted his life to advocating for the 
disease, a job that requires extensive outreach to the local community about symptoms 
and ways to protect themselves from dust; to major companies in the area to protect their 
workers, and to national organizations like the American Lung Association to try to raise 
funding for more research. He wishes he had time to fly fish, or to tend to the horses he 
keeps on his property in the mountains by Lake Isabella, but instead many of his nights 
are sleepless, dominated by racing thoughts on how he can get more people outside of 
Kern County to care about valley fever and the people at risk for contracting it. “It means 
something to the Central Valley,” Emery says, “but it’s an orphan disease.”  
 
It’s also, to Emery, a compelling one. “This [disease] is particularly fascinating for 
people who love to solve puzzles. When I got to Kern, it just drew me in.” 
 
Emery’s lab tests blood serum from every person potentially infected with valley fever in 
all of Kern County – roughly 20,000 tests a year. It’s monotonous, brain-numbing work, 
done by hand with just a handful of employees. Terry Oubsuntia – his primary 
microbiology specialist in charge of testing – has a fondness for bolo ties and for 
spinning his pipettes like pistols as he tests each sample, hundreds of them a week. Under 
the protective glass casing at his workstation, the cocci fungus he cultures for testing 
looks like really moldy bread. It’s been several years since he moved to Kern County 
from Thailand and, so far, he’s remained disease-free. But the prospect of catching valley 
fever is worrisome enough that he personally tests his own blood serum every few 
months.  
 
*** 
 
Fungi are nature’s great garbage disposals. Some species of fungi are saprophytes – 
Sapros in Greek, means rotten – so they thrive off of dead or rotting materials, like wood 
or mammals. Cocci, a particularly virulent saprophyte, lives just as well in the soil as it 
does in humans, where the lung seems to be a favorite habitat.  
 
But cocci’s life cycle begins in the dirt. As the fungus develops, it forms spindly, white 
chains that grow rapidly in the soil following rainfall. Moisture is a critical component of 
its life cycle, but too much dampness prevents the chains from forming into tiny, barrel-
shaped packages of dormant spores that help the fungus survive during drier periods. The 
spores break apart easily when airborne, and when carried on the breeze, they either settle 
in new soils to reproduce, or – if a human happens to breathe them in – in the warm, 
moist environments of our lungs.  
 
Cocci is a clever microbe. It’s dimorphic, able change its shape to maximize its survival 
in the ground – when it’s a spindly filament – or in the body, as a circular blob packed 
with little endospores. These spores function much like the barrel-shaped packages that 
break off in the soil: They help the fungus spread throughout the body as quickly as 
possible.  
 
When inhaled, the spores heads straight to the tiny, hollow sacs located at the ends of our 
air passageways. These little purses are lined with very thin, wet walls – about one cell 
thick -- surrounded by a network of capillaries. It’s here where oxygen and carbon 
dioxide enter and leave the lungs when we breathe, and where the cocci spherules start to 
multiply, feeding off the body’s flesh. As the spherules mature and swell, they eventually 
burst, releasing hundreds of little spores that each form into a new spherule with 
hundreds of little spores of their own, starting the cycle all over again.   
 
By time the cocci sets up shop in the lungs, the body’s immune system has already 
kicked into overdrive, sending out immune cells to the infection site bent on a single task: 
seek and destroy. Their goal is to recognize the fungus – specifically, the unfamiliar 
markers on it, also known as antigens, that first alerted the body to an invader – and 
either dissolve or kill it off. But cocci will do whatever’s necessary to evade the immune 
system. It’s able to change its own markings, successfully deceiving immune cells to fend 
off their attack. Unlike viruses, which need a living host to survive, pathogenic fungi like 
cocci depend on living or decaying matter. And the sooner it’s dead, the better.  
 
*** 
 
The world’s first reported case of valley fever dates back to 1892, to a 36-year-old 
Argentinian cavalry soldier named Domingo Ezcurra. What started with a lesion on his 
right cheek soon spread and worsened into red, itchy spots and oozing, pus-filled 
ulcerating papules. Before long, most of his right cheek became covered with a single, 
large purple fungal growth. The cauliflower-like excrescences baffled doctors.  
 
Meanwhile, just a year after Ezcurra’s case was reported, a Portuguese immigrant farm 
laborer named Joas Furtado Silveira checked into a San Francisco hospital more than 
6,000 miles away with similar mysterious skin lesions. Silveira had just immigrated from 
the Azores to Modesto, and a spot enlarging on the back of his neck was concerning him, 
a minor nuisance from an irritating collar, he thought. Yet, as with Ezcurra, new growths 
soon started to form. They grew around his eyebrows, forming grotesque bulbous lumps 
that nearly swelled his eyes shut. Silveira eventually lost both of his eyes, his nose, part 
of his upper lip, and half an ear. It’s unclear whether his horrible disfigurement was 
caused by valley fever specifically, or by his medical treatment, which was rudimentary 
at best. It included a toxic cocktail of topical methyl violet – used in purple dye – 
potassium permanganate – one of the principal chemicals used in film and television sets 
to create an “ancient” look on cloth or glass – and carbolic acid.  
 
Both the Argentinian solider and the Portuguese farmworker eventually died, after years 
of painful, horrendously disfiguring cysts, unsuccessful treatment, and before there was 
any understanding of the mystery illness that plagued them. Silveira managed to leave 
scientists with one significant clue, though. Doctors were stunned by what they saw 
during his autopsy: his body was riddled with nodules in places like his lungs, lymph 
nodes, spleen, testes, prostate, and liver. When they later examined the nodules under a 
microscope, they were full of tiny, wriggling organisms: cocci.  
 
The peculiar nature of the men’s mutilating illness intrigued two doctors, Emmet Rixford, 
a surgeon at San Francisco’s Cooper Medical College (which later became Stanford 
University Medical School), and T. Caspar Gilchrist, a pathologist at Johns Hopkins 
Medical School in Baltimore. They took skin samples from Silveira during the course of 
his treatment, and christened the organism Coccidoides, for resembling Coccidia – a 
parasitic disease infecting the intestinal tract of animals – and immitis, Latin for severe.  
 
A few years later, in August 1901, the inexplicable disease was reported for the first time 
in Kern County. This time, the victim was a 19-year-old man who worked as a canner 
and had been a resident of the county for only 12 days before showing symptoms. By 
then, less than 10 cases of what would later turn out to be called valley fever had been 
reported across the United States. “They thought it was plague, they thought it was 
leprosy, they thought it was all kinds of things,” Emery says. It took a laboratory accident 
in 1929 before scientists understood that valley fever symptoms cover a wide spectrum of 
mild and serious health effects. Within nine days of opening a petri dish full of cocci 
mold and breathing in its spores, 26-year-old Harold Chope, a Stanford University 
medical student at the time, became ill with acute pneumonia. Four weeks later, nodules 
erupted on his shins and scientists found cocci spherules in the mucus produced from his 
cough. Fears over his impending death made the national news, but Chope surprisingly 
made a full recovery. Valley fever, they realized, was much more complex than they [who?] 
thought.   
 
*** 
 
Adan Barragan was just seventeen when he left his home in Colima, a picturesque beach 
town on Mexico’s Pacific Coast, for California to work in the fields more than a decade 
ago. He settled in Delano, Kern County’s second largest city after Bakersfield, and a 
central hub of farmworker organization efforts and Chicano movement politics in the 
1950s. Before long Barragan was a farmworker himself, harvesting peaches, and then 
picking, pruning and packing grapes, Kern’s top grossing commodity. Now 29, he lives 
in a modest tract home in Delano with his wife and four young children. He digs 
irrigation lines and sprays pesticides for Grapeman Farms, a local grower. It’s 
backbreaking work that seems possible only with a sturdy build like his, all 220 pounds 
of it. He has to manage nearly 4,000 acres of land, which when split between five other 
people, requires putting in 10 to 12 hour shifts in the fields, six days a week.  
 
Last October, Barragan noticed a tiny bump in the middle of his chest. It looked like a 
pimple, he says, so he didn’t think much of it at first. But then it started growing. Before 
long, it was the size of a bright red baseball, hard to the touch and oozing pus. The bigger 
it grew, the harder it became for him to breathe, and to lift and carry the heavy machinery 
he operates in the fields as he tends grapes. His wife, Alma Ramos, worried it was 
cancerous, and urged Barragan to seek medical attention at Kern Medical Center. He was 
diagnosed immediately with valley fever.  
 
A small number of valley fever infections, roughly five percent, turn into what doctors 
deem “the valley fever complex,” eruptions of fiery red clusters and painful pustules on 
the shins, thighs, arms or buttocks, that flare up if the fungus leaves the lungs and spreads  
from the lymphatic system to the blood stream, which carries it throughout the body. For 
reasons unknown, some patients go on to develop arthritis, most commonly in the ankles 
or knees, or chronic pneumonia after the bumps clear. About five to ten percent of cocci-
related chest infections result in lasting damage, like scarring, nodules or cavities in the 
lungs, which when seen under an X-ray, are often misdiagnosed as cancer.  
 
Barragan’s extensive exposure to the soil at Grapeman Farms puts him at a higher-risk of 
developing valley fever, but Ramos says they had never heard of the disease before, or 
realized how serious it could be. It was a total wakeup call.  
 
“If we knew more about it, he probably would have been more careful,” Ramos says, 
translating for Barragan, who only speaks Spanish. “I hear valley fever and all I think is 
‘fever.’ So I’m thinking a cold. He probably had symptoms before and we didn’t know.” 
Barragan still works as a farm laborer, but his health scare was enough to convince him 
to start considering other work, like enlisting in the military or the Navy. “He’s learning 
English,” Ramos says. “He’s going to get a high school diploma, because he doesn’t want 
to be out in the fields anymore.” 
 
While Barragan was in the hospital, he underwent a strict regimen of the antifungal 
fluconazole, delivered intravenously three days a week for three months. Sometimes the 
treatments lasted for hours at a time. The medicine gave him seizures, and caused him to 
shed weight, about 50 pounds over the course of his stay. The use of other oral azole 
treatments, like fluconazole, in combatting valley fever traces to advancements in the 
HIV epidemic. When azole therapies were found to ease symptoms for HIV-positive 
patients with suppressed immune systems in the late 70s and early 80s, researchers 
studying cocci decided to test whether they could combat fungal infections, too. Because 
antifungals are rarely administered directly to the infection site – with the exception of 
shunts to convey them directly into the brain to combat meningitis – the hope is that 
enough can be pumped throughout the body to target the fungus wherever it is. Yet even 
with advances in treatment, the sustained use of antifungals – whether orally or 
intravenously – can cause permanent kidney damage. “With the oral medications, why it 
gets scary is that they see how much the patient can tolerate,” Emery says. “It’s not like 
with other drugs when they say, ‘OK, we know this body weight and we give them this 
specific amount of medication.’ It’s how much can this person tolerate.” 
 
Barragan’s symptoms responded to the treatment: the pustules subsided, and he started 
regaining his strength. Yet Even now, Barragan is supposed to take up to 10 pills of 
fluconazole a day for the next three years to prevent any symptoms from remerging. He’s 
wary of experiencing any more side effects, like the extreme tiredness that put him out of 
work for four months, but he considers himself fortunate; of the ten other patients also in 
treatment for valley fever during his stay in the hospital, four of them died from 
“disseminated” disease he says.  
 
Disseminated valley fever is one of the greatest conundrums surrounding the illness. It 
only occurs in one percent or less of infections, but its damage to the skeletal system, 
joints, lungs or meninges – the delicate and precious membranes that enclose the brain 
and spinal cord – is vicious. The fungus can decompose the vertebrae, skull, ribs and long 
bones, like the femur and tibia, or the joints of the knees, wrists, ankles and elbows. 
Meningitis, the most serious manifestation of disseminated cocci, happens if the fungus 
manages to break into the brain and spinal cord. To keep a patient alive, treatment – 
either with oral medications or a shunt inserted directly into the brain – must last a 
lifetime.  
 
“It just scares me – I have a kid that lives down in Bakersfield,” Emery says in his office, 
surrounded by piles of maps of Kern County and studies on valley fever dating back to 
the early 1900s. An image of a preserved human head in a jar covered in pustules – one 
of the first known valley fever patients ever recorded – is projected on a PowerPoint 
presentation on the wall behind him. “We live up in the mountains and I work down here, 
but the fact of the matter is that [getting infected] is a game changer. Your life has to 
revolve around getting these drugs or you die. No one will take their patients off of 
medication believing that they’ll survive. We’ve tried. Everything looks healthy, 
everything looks normal, and then we try taking them off the medication and they go 
back to disease state.” 
 
Disseminated cocci might be rare, but if a patient is black or Filipino, the rates of 
developing it jump from 1 percent or less, to higher than 50 percent, one of the strongest 
arguments for developing a vaccine. “It’s the $64,000 question,” Stevens says, as to why 
such ethnic groups are at such heightened risk. “If we knew, we’d know a lot more about 
protecting people.”  
 
*** 
 
At first glance, a framed photograph hanging on the wall of George Rutherford’s office 
looks like a vast tide receding toward the crest of a giant, foaming wave. It’s actually a 
tsunami of dust, the “Tempest from Tehachapi,” one of the worst dust storms in history. 
“You just have to inhale one spore,” says Rutherford, a professor of epidemiology and 
preventive medicine at UC San Francisco. “The risks of getting a face full of this stuff all 
depends on where you are, what the climate is.”  
 
A dust storm can begin with just a few particles of dry soil and a strong draught of wind. 
Once swooped off the ground, these particles start to vibrate and bounce, propelled by 
increasing gusts. They break into smaller pieces each time they hit the ground. Each time 
the lighter dust particles descend downward into the heavier ones, which stay near the 
bottom of the storm, they’re propelled farther upward. The storm escalates as the dust 
climbs higher and higher, ricocheting off each other with intensifying speed. When 
Tempest from Tehachapi struck Bakersfield in 1977, it lasted for 48 hours. The storm 
rose nearly 10,000 feet, producing a towering cloud of dust that cut visibility to less than 
a quarter mile, and dimmed the sun as far north as Reno.  
 
Wind gusts during the storm topped 192 miles per hour; strong enough to strip paint off 
of cars, topple airplane hangars and permanently alter much of Bakersfield’s landscape 
from fertile farmland, to eroded, sandy soil. The storm caused nearly 40 million in losses 
– not including the irreparable damage sustained to valuable farm and cropland – and 
deposited 25 million metric tons of soil and bedrock on the surrounding area. The dust, 
borne on high currents, eventually settled as a “mud storm” on sidewalks and cars across 
much of California. It was inescapable; it seeped through windows and door cracks, 
depositing fine layers of grime on car seats and furniture. After the storm, Bakersfield 
looked more like a Depression-era Dust Bowl town in the Great Plains than a city in the 
Central Valley. Some local accounts likened the scene to a post-apocalyptic nuclear 
attack, or to the set of a bizarre, sci-fi movie. One Kern County resident even went as far 
as to describe the phenomenal deposit of dirt in her swimming pool as “the result of a 
Fleet’s enema.” 
 
The dust was also lethal, and laden with cocci spores. They were carried as far north as 
San Francisco, Marin County, Sacramento, Santa Clara and even Oregon, sickening 
several hundred people well outside the Central Valley with valley fever, including a 
gorilla at the San Francisco Zoo, who ultimately died from the disease.  
 
Cocci is quite resilient in the soil, but if temperature or moisture levels aren’t just right, it 
goes dormant, to a non-infectious state. During extended periods of hot, dry weather, 
when the top levels of soil become partially sterilized, cocci somehow stays alive by 
moving deeper into the dirt. When it finally rains again, and the soil becomes fertile once 
more, it migrates back to the surface.  
 
“It’s sort of like Invasion of the Body Snatchers,” says Garrison Sposito, a professor of 
Soil Science at UC Berkeley. “They stay in the soil as these little spores, they wait for the 
right conditions, and then they pop right back out again. It’s creepy.” 
 
*** 
 
Kern County’s first  “Great Epidemic” of valley fever began in 1991 and lasted for three 
years, the result of a particularly rainy spring following a five-year drought. In just one 
year – from 1991 to 1992 – cases jumped from 959 to over 3,000 sicknesses. Counting 
asymptomatic patients, though, some doctors think up to 8,000 people may have been 
infected with valley fever in that period.  
 
The surge was alarming, but Emery says interest and funding for the disease disappeared 
completely two years after the epidemic ended. This was about as shocking to him as 
deciding to de-fund cancer research. “We put fire stations everywhere to protect you, but 
when it comes down to public health, you’re fighting for everything. Sheriffs, fire, police, 
they all have their challenges, but what we do doesn’t necessarily get seen until 
something bad happens, like a big outbreak of cocci, H1N1, or bioterrorism,” he says. 
“When something like that happens, all of the sudden we get funding, but it just seems 
like we continuously chase our tails.”  
 
When a second valley fever epidemic hit Kern County in 2001 – it’s still ongoing – 
Emery vowed to become more outspoken in his advocacy for state and federal support. 
“What we measure in public health, in our successes and in our failures, typically tends to 
be in 10 year increments,” he says. “I looked at what happened after the first time around 
and that’s why I was so vocal the second time. I don’t have another ten years to sit 
around here hoping for another epidemic to see if we can get some action here.”  
 
It took the deaths of more than three-dozen inmates from valley fever since 2006 at two 
nearby state prisons, Avenal and Pleasant Valley, before Kern County’s epidemic 
received the national attention Emery had been waiting for. The CDC began an 
investigation last May, and a federal judge mandated a transfer of more than 2,500 at-risk 
inmates out of Kern County. Because the prisons house high concentrations of black and 
Filipinos inmates, valley fever infection rates are astronomical there compared to the 
state average; 1,000 times higher at Pleasant Valley, where more than 1,000 inmates have 
contracted valley fever over the past five years, and 189 times higher at Avenal. In 
September, the National Institutes of Health and the CDC announced plans to start a 
clinical trial in Bakersfield, in hopes of understanding how early diagnosis affects the 
course of treatment and finally developing a vaccine.   
 
Another hopeful development spurred by Kern County’s most recent epidemic is the 
reintroduction of a skin test to diagnose the disease. First developed in the 1920s, the test 
used to be one of the fastest ways to diagnose valley fever, but it was discontinued after 
the FDA charged pharmaceutical companies more than $700,000 in marketing fees to sell 
the test For years, Emery and his cohort have pressed the FDA to waive the fee – possible 
if the Administration rules there is a substantial threat to public health. It was finally 
waived earlier this month, and the $20 skin test should be back on the market by the end 
of this year. If someone tests positive for valley fever using the skin test, but has never 
shown any symptoms in their lifetime, the prognosis is good; it generally means their 
immune system has prevented a chronic infection. Using the skin test, prisons in the 
Central Valley, for example, would be able to test all of their inmates, and then transfer 
those at high risk of developing disseminated disease, like blacks and Filipinos, to other 
prisons.  
 
Because of the widespread screening, “It won’t let the state get out of cocci as easy,” 
Emery says. “Now that there’s more of a system, the state can analyze the major players 
[like Kern],” Emery says. They can’t use a lack of data as a scapegoat to avoid 
acknowledging that they have a problem.” 
 
Seventy years after the first valley fever patient was diagnosed in Argentina, the prospect 
for a safe, effective therapy or, better yet, a vaccine, still remains uncertain. Developing a 
vaccine for valley fever would mean creating a financial incentive lucrative enough to 
draw Big Pharma into producing a product that only a relatively small portion of the 
entire country would ever use. The government-backed CDC clinical trial and the 
reintroduction of the skin test should give us a better idea how extensive the problem is, 
but whether this will be enough to inspire research from pharmaceuticals is doubtful. 
There are less and half a dozen researchers nationwide working toward a vaccine – 
primarily in California, Texas, and Arizona – and Emery believes the effort needs another 
big infusion of money to push it over the top. It could be decades before a vaccine is 
perfected in the lab. 
 
Yet the question remains whether valley fever would still be as mysterious or overlooked 
if it didn’t affect some of California’s poorest and most powerlessness residents. Kern 
County, the state’s disease epicenter, is a hub for farm laborers, not investment bankers, 
media types, politicians or tech start-ups, making the issue much easier to ignore. 
Farming in Kern might be a $6 billion enterprise, but the reality is that one out of three 
children under the age of five lives in poverty there. 
 
“Most of the other vaccines that we’re dealing with now were sort of a big full court 
press government thing,” Rutherford says. “If you look at the AIDS vaccine efforts, you 
know, [their budgets] are astronomical. The amounts of money spent, and properly so, 
are very high. I can guarantee that this is true, that if this disease were happening in 
Washington, DC, the conversation wouldn’t be, “Well, these diseases have been around 
since the ‘40s.’”  
 
Emery for whom retirement beckons within the next decade, feels an obligation to stay 
on the job as long as valley fever remains a puzzle. He says he’s “scared to death” that 
when he leaves the Kern County’s public health department, so too will local pressure to 
confront valley fever. He wonders if there will be someone as passionate about a tiny, 
regional mystery fungus as he is, or as the other doctors before him, like Emmet Rixford 
or Harold who revolutionized treatment and even infected themselves with the disease for 
the sake of understanding the cause.  
 
“It’s my disease. It’s Kern County’s disease,” he says, adding that his work will probably 
never be done in his lifetime. “I was up the other night, frustrated as hell and thinking I 
should be reviewing my statistics. Even if you call me an epidemiologist and say I’m just 
a mediocre cocci guy, and he’s not doing the CDC studies, I have made a stink and we’ve 
actually gotten some attention. This disease needs a voice. If I die tomorrow on my 
motorcycle, I’ll die with a smile. I got involved and I made a difference.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source List: 
 
Kirt Emery  
Health Assessment and Epidemiology Program Manager 
Kern County Department of Public Health   
(661) 868-0303 
Cell: (661) 330-5407 
emeryk@co.kern.ca.us 
 
Terry Oubsuntia 
Microbiologist specialist 
Kern County Department of Public Health 
661.321.3000  
 
David Stevens 
Professor Emeritus of Medicine, Stanford University Medical School 
Chief of the Division of Infectious Diseases and Hospital Epidemiologist, Santa Clara 
Valley Medical Center 
stevens@stanford.edu 
 
Adan Barragan and Alma Ramos  
Valley fever patient  
(661) 229- 3103 
 
George Rutherford 
Salvatore Pablo Lucia Professor of Epidemiology, Preventive Medicine and Pediatrics 
Vice Chair, Department of Epidemiology and Biostatistics 
Head, Division of Infectious Disease Epidemiology 
University of California, San Francisco 
(415) 597-9108 
grutherford@psg.ucsf.edu 
 
Garrison Sposito 
Professor, Betty and Isaac Barshad Chair in Soil Science 
University of California - Berkeley 
510-643-8297 
gsposito@berkeley.edu 
 
George R. Thompson, M.D. 
Assistant Professor of Medicine 
Codirector, Coccidioidomycosis Serology Laboratory 
Department of Medical Microbiology and Immunology 
Department of Medicine, Division of Infectious Diseases 
University of California - Davis 
530-752-3545 
grthompson@ucdavis.edu 
Coccidioidomycosis: New Aspects of Epidemiology and Therapy, Hans E. Einstein and 
Royce H. Johnson. Clinical Infectious Diseases Vol. 16 No 3 (March 1993) pp. 349-354 
 
Coccidioides infection (Coccidiomycosis) II. The Primary Type of Infection Ernest C. 
Dickson, MD. San Francisco, and Myrnue A. Gifford, MD Bakersfield, CA NOV. 1938, 
Vol. 62 No 5  
 
Risk Factors for Severe Pulmonary and Disseminated Coccidioidomycosis Kern County, 
California, 1995-1996. CID 2001:32 (1 March) Rosenstein et al.  
 
Practice Guidelines for Treatment of Coccidioidomycosis Galgiani et al. Clinical 
Infectious Diseases 2000; 30: 658-61 
 
Head and Neck Manifestations of Disseminated Coccidioidomycosis Arnold et al. 
Laryngoscope 114: April 2004 
 
Occupational Coccidioidomycosis in California, Outbreak Investigation, Respirator 
Recommendations, and Surveillance Findings, Das et al. JOEM Vol 54, Number 5, May 
2012 
 
The early history of coccidioidomycosis: 1892-1945. Hirschmann JV. Clin Infect 
Dis. 2007 May 1;44(9):1202-7. Epub 2007 Mar 19. 
 	  
 
 
 
 
 
 
 	  
